id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0374-0006,FDA,FDA-2004-D-0374,FDA,Notice,NAD-Notice of Availability of Data,2006-01-09T05:00:00Z,2006,1,2006-01-03T05:00:00Z,,2008-04-12T00:36:01Z,,0,0,0900006480473741
FDA-2004-D-0374-0005,FDA,FDA-2004-D-0374,Guideline,Supporting & Related Material,GDL-Guidance,2006-01-05T05:00:00Z,2006,1,,,2008-04-12T00:36:01Z,,0,0,0900006480473740
FDA-2004-D-0374-0004,FDA,FDA-2004-D-0374,Guideline,Supporting & Related Material,GDL-Guidance,2006-01-05T05:00:00Z,2006,1,,,2008-04-12T00:36:01Z,,0,0,090000648047373f
FDA-2004-D-0374-0001,FDA,FDA-2004-D-0374,FDA,Notice,NAD-Notice of Availability of Data,2004-12-06T05:00:00Z,2004,12,2005-12-01T05:00:00Z,2005-02-01T04:59:59Z,2008-04-12T00:36:01Z,,0,0,090000648047372b
FDA-2004-D-0374-0002,FDA,FDA-2004-D-0374,Guidelines,Supporting & Related Material,GDL-Guidance,2004-12-06T05:00:00Z,2004,12,,,2008-04-12T00:36:01Z,,0,0,090000648047372c
FDA-2004-D-0374-0003,FDA,FDA-2004-D-0374,Guidelines,Supporting & Related Material,GDL-Guidance,2004-12-06T05:00:00Z,2004,12,,,2008-04-12T00:36:01Z,,0,0,090000648047372d